Reversal of Spinal Cord Damage using Stem Cell Therapy

AI Thread Summary
The recent 60 Minutes segment featuring Hans S. Keirstead highlighted groundbreaking research on reversing spinal cord damage using human embryonic stem cells. Keirstead's study, published in the Journal of Neuroscience in May 2005, demonstrated that transplantation of human embryonic stem cell-derived oligodendrocyte progenitor cells (OPCs) into injured rat spinal cords significantly enhances remyelination and improves motor function. The research indicates that OPCs injected shortly after injury lead to notable locomotor recovery, while delayed injections do not yield the same results. This promising approach could bring human clinical trials for spinal cord injury therapies closer, potentially starting as early as next year, offering hope for individuals with paralysis to regain mobility.
Ouabache
Science Advisor
Homework Helper
Messages
1,345
Reaction score
8
Did anyone happen to catch the 60mins TV spot of Hans S. Keirstead last night?

His research showing reversing spinal cord damage in rats using human embryo stem cells is compelling. Brings this approach to humans paralyzed by spinal cord damage, closer to reality. Human clinical trials may be approved as early as next year.

His findings were published in Journal of Neuroscience last May 2005

Hans S. Keirstead, Gabriel Nistor, Giovanna Bernal, Minodora Totoiu, Frank Cloutier, Kelly Sharp, and Oswald Steward
Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cell Transplants Remyelinate and Restore Locomotion after Spinal Cord Injury
J. Neurosci., May 2005; 25: 4694 - 4705 ; doi:10.1523/JNEUROSCI.0311-05.2005

Demyelination contributes to loss of function after spinal cord injury, and thus a potential therapeutic strategy involves replacing myelin-forming cells. Here, we show that transplantation of human embryonic stem cell (hESC)-derived oligodendrocyte progenitor cells (OPCs) into adult rat spinal cord injuries enhances remyelination and promotes improvement of motor function. OPCs were injected 7 d or 10 months after injury. In both cases, transplanted cells survived, redistributed over short distances, and differentiated into oligodendrocytes. Animals that received OPCs 7 d after injury exhibited enhanced remyelination and substantially improved locomotor ability. In contrast, when OPCs were transplanted 10 months after injury, there was no enhanced remyelination or locomotor recovery. These studies document the feasibility of predifferentiating hESCs into functional OPCs and demonstrate their therapeutic potential at early time points after spinal cord injury.
 
Last edited:
Biology news on Phys.org
Yes, I did view the program and it was very interesting.
 
Indeed, I didn't realize we were that close to implementing a therapy that may repair the nerves in the spinal chord and allow para and quadrapalegic individuals a means of acquiring mobility.
 
Chagas disease, long considered only a threat abroad, is established in California and the Southern U.S. According to articles in the Los Angeles Times, "Chagas disease, long considered only a threat abroad, is established in California and the Southern U.S.", and "Kissing bugs bring deadly disease to California". LA Times requires a subscription. Related article -...
I am reading Nicholas Wade's book A Troublesome Inheritance. Please let's not make this thread a critique about the merits or demerits of the book. This thread is my attempt to understanding the evidence that Natural Selection in the human genome was recent and regional. On Page 103 of A Troublesome Inheritance, Wade writes the following: "The regional nature of selection was first made evident in a genomewide scan undertaken by Jonathan Pritchard, a population geneticist at the...
Back
Top